Our work is focused on understanding how the exhausted T cells in the tumour environment are different to those developing in the autoimmune islet environment. Understanding this will allow us to exploit processes that make T-cells causing T1D more exhausted like those in cancer and prevent T1D.
To do this we have developed a novel transplantable tumour cell line expressing islet antigen(s). We hypothesise that islet antigen-specific T cells infiltrating the tumour will undergo severe T cell exhaustion. To examine how exhausted islet-specific T cells regulate the other effector T cells in NOD mice we will remove the tumour and follow the NOD mice to see if they are protected from diabetes.
Supervised by
Available for Student Supervision